We advised Advent International, a leading global private equity investor, on its agreement to acquire a significant minority stake in Felix Pharmaceuticals Pvt Ltd, a leading global Gx animal pharma player. 

Our team was led by Michael Coyle (Corporate and M&A) and included Tim Gleeson, Daire Cassidy, Glyn McCormack and Sondos Siddiqi (Corporate and M&A), David Kilty and Nicola Cavey (Tax), Simon Breen and Robert Byrne (Competition and Regulated Markets) and Colin Kavanagh (Life Sciences).

More information is available on the Advent website.